Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-rgd nanospheres

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3351-3365

  Chang, Run ^a   Sun, Linlin ^a   Webster, Thomas J ^a,b  

^a Northeastern University   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Arginine glycine aspartic acid; Arginine rich; Curcumin; Osteosarcoma; Selective inhibition; Self assembly

Indexed keywords

ACETIC ACID; AMPHIPHILIC NANOPARTICLE; ARGINYLGLYCYLASPARTYLSERINE; CURCUMIN; NANOPARTICLE; NANOSPHERE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; WATER; ANTINEOPLASTIC AGENT; ARGININE; ARGINYL-GLYCYL-ASPARTIC ACID; DRUG CARRIER; OLIGOPEPTIDE;

AQUEOUS SOLUTION; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DIALYSIS; DRUG CYTOTOXICITY; DRUG SOLUBILITY; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MG 63 CELL LINE; OSTEOBLAST; OSTEOSARCOMA CELL LINE; PH; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL; BONE NEOPLASMS; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; OSTEOSARCOMA; PATHOLOGY; SOLUBILITY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ARGININE; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DRUG CARRIERS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSPHERES; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOSARCOMA; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84929439278     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S78756     Document Type: Article

References (46)

1. Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011;2011: 959248.
2. He JP, Hao Y, Wang XL, et al. Review of the molecular patho-genesis of osteosarcoma. Asian Pac J Cancer Prev. 2014;15(15): 5967–5976.
3. Cotterill SJ, Wright CM, Pearce MS, Craft A W. Stature of young people with malignant bone tumors. Pediatr Blood Cancer. 2004;42(1): 59–63.
4. Ottaviani G, Jaffe N. The Etiology of Osteosarcoma. In: Jaffe N, Bruland ØS, Bielack SS, editors. Pediatric and Adolescent Osteosarcoma. Houston, TX, USA; Springer; 2009:15–32.
5. Dutra FR, Largent EJ. Osteosarcoma induced by beryllium oxide. Am J Pathol. 1950;26(2):197–209.
6. Pollard TD, Earnshaw WC. Cell Biology. 2nd ed. Philadelphia, PA, USA: Saunders Elsevier; 2008.
7. Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE. c-Fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-Jun and the role of endogenous c-Fos. Cancer Res. 1995;55(24): 6244–6251.
8. Staudt LM. Oncogenic activation of NF-kB. Cold Spring Harb Perspect Biol. 2010;2:a000109.
9. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic infammatory diseases. N Engl J Med. 1997;336(15):1066–1071.
10. Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008;10(3):511–545.
11. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:12.
12. Brennan P, O’Neill LA. Inhibition of nuclear factor κB by direct modification in whole cells – mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifers. Biochem Pharmacol. 1998;55(7): 965–973.
13. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinfammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163(6):3474–3483.
14. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem. 2005;280(20): 20059–20068.
15. Liu E, Wu J, Cao W, et al. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol. 2007;85(3):263–270.
16. Collins HM, Abdelghany MK, Messmer M, et al. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer. 2013;13:37.
17. Kumar A, Ahuja A, Ali J, Baboota S. Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst. 2010;27(4):279–312.
18. Tønnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Pharmazie. 2002;57(12):820–824.
19. Ramanathan M, Shrestha LK, Mori T, Ji Q, Hill JP, Ariga K. Amphiphile nanoarchitectonics: from basic physical chemistry to advanced applications. Phys Chem Chem Phys. 2013;15(26):10580–10611.
20. Tu RS, Tirrell M, Bottom-up design of biomimetic assemblies. Adv Drug Deliv Rev. 2004;56(11):1537–1563.
21. Zhao X, Pan F, Xu H, et al. Molecular self-assembly and applications of designer peptide amphiphilies. Chem Soc Rev. 2010;39(9): 3480–3498.
22. Raj A, Saraf P, Javali NM, Li X, Jasti B. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery. J Drug Target. 2014;22(6):518–527.
23. Javali NM, Raj A, Saraf P, Li X, Jasti B. Fatty acid-RGD peptide amphiphilic micelles as potential paclitaxel delivery carriers to αvβ3 integrin overexpressing tumors. Pharm Res. 2012;29(12):3347–3361.
24. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430): 1028–1032.
25. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinet-ics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597–6611.
26. Futaki S, Hirose H, Nakase I. Arginine-rich peptides: methods of trans-location through biological membranes. Curr Pharm Des. 2013;19(16): 2863–2868.
27. Nakase I, Tadokoro A, Kawabata N, et al. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry. 2007; 46(2):492–501.
28. Nakase I, Niwa M, Takeuchi T, et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther. 2004;10(6):1011–1022.
29. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem. 2002;45(17): 3612–3618.
30. Chen JX, Wang HY, Quan CY, Xu XD, Zhang XZ, Zhuo RX. Amphiphilic cationic lipopeptides with RGD sequences as gene vectors. Org Biomol Chem. 2010;8(14):3142–3148.
31. Southall NT, Dill KA, Haymet AJ. A view of the hydrophobic effect. J Phys Chem B. 2002;106(3):521–533.
32. Chandler D. Interfaces and the driving force of hydrophobic assembly. Nature. 2005;437(7059):640–647.
33. Nagarajan R, Ruckenstein E. Theory of surfactant self-assembly: a predictive molecular thermodynamic approach. Langmuir. 1991; 7(12):2934–2969.
34. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv. 2007;4(4):403–416.
35. Bellamy LJ. The Infra-Red Spectra of Complex Molecules. 2nd ed. London, UK: Chapman and Hall Ltd; 1958.
36. Xu XD, Chen JX, Cheng H, Zhang XZ, Zhuo RX. Controlled peptide coated nanostructures via the self-assembly of functional peptide building blocks. Polym Chem. 2012;3:2479–2486.
37. Khaw AK, Hande MP, Kalthur G, Hande MP. Curcumin inhibits telom-erase and induces telomere shortening and apoptosis in brain tumour cells. J Cell Biochem. 2013;114(6):1257–1270.
38. Chang R, Sun L, Webster TJ. Short communication: selective cytotox-icity of curcumin against osteosarcoma cell lines compared to healthy osteoblasts. Int J Nanomedicine. 2014;9:461–465.
39. Jin S, Xu HG, Shen JN, Chen XW, Wang H, Zhou JG. Apoptotic effects of curcumin on human osteosarcoma U2OS cells. Orthop Surg. 2009;1(2):144–152.
40. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer. 2004;90(3):561–565.
41. Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin αvβ3 targeted radiotracers for tumor imaging. Mol Pharm. 2006;3(5): 472–487.
42. Hassenpfug WA, Tschan MP, Torbett BE, Habermann BF. Integrin alpha(v)beta(3) and osteopontin promote hematogenous metastasis of osteosarcoma cells to the lung. Thromb Res. 2007;120:S172.
43. Williams AC, Barry B W. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603–618.
44. Notman R, Noro M, O’Malley B, Anwar J. Molecular basis for dim-ethylsulfoxide (DMSO) action on lipid membranes. J Am Chem Soc. 2006;128(43):13982–13983.
45. David NA. The pharmacology of dimethyl sulfoxide 6544. Annu Rev Pharmacol. 1972;12:353–374.
46. Hanslick JL, Lau K, Noguchi KK, et al. Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis. 2009;34(1):1–10.